Delivery Order SPE2DB22D3004-SPE2DB25FQA43

Award Date 3/25/25
Potential Completion Date 4/15/25
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,473.50, is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product. The contract is a firm fixed-price, non-set-aside arrangement with a performance period through May 21, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical products. The contract has a firm fixed-price pricing type and a ceiling value of $36,490.00. The period of performance extends until May 29, 2025. This delivery order is placed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,473.50, is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, providing a comprehensive global pharmaceutical support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $7,298.00 and a completion date of February 26, 2025. The contract is a firm fixed-price delivery order, without any set-aside requirements. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,298.00, is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 26, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,264.25, is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a pharmaceutical product. The contract has a period of performance through August 17, 2023 and is a Firm Fixed Price contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML. The contract has a ceiling value of $7,298.00 and runs through January 3, 2025. The contract was awarded on December 11, 2024 and uses a firm fixed price pricing type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $3,649.00. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $10,228.88 contract is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a pharmaceutical product, with a completion date of May 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025 for a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,649.00, is a Firm Fixed Price Delivery Order for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical products. The award has an ultimate completion date of April 9, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FQA43
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,473.50, is for the provision of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product used in healthcare applications.

The contract is a Firm Fixed Price type and was awarded on March 25, 2025, with a performance period extending to April 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order contract is a part of that larger IDC framework.

The contract does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor, AmerisourceBergen plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.

Generated 6/24/25, 9:44 AM